UK: During a debate about treatments for children with epilepsy, the minister for care and mental health, Gillian Keegan, said that the National Institute for Health Research (NIHR) and the NHS will support a programme of two randomised control trials on epilepsy, which will compare medicines containing cannabidiol, and CBD plus tetrahydrocannabinol and a placebo. “This is a pioneering area » Continue Reading....
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.